The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms.
about
Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future researchTGF-beta: a crucial component of the pathogenesis of diabetic nephropathyDetermination of an angiotensin II-regulated proteome in primary human kidney cells by stable isotope labeling of amino acids in cell culture (SILAC)Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cellsEpigenetic histone methylation modulates fibrotic gene expressionPolyol-pathway-dependent disturbances in renal medullary metabolism in experimental insulin-deficient diabetes mellitus in rats.Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms.Serum arylhydrocarbon receptor transactivating activity is elevated in type 2 diabetic patients with diabetic nephropathyAT1 receptor antagonists: a challenge for ACE inhibitors in diabetic nephropathy.Plasminogen activator inhibitor-1 and the kidney.The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy.Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?Products of 12/15-lipoxygenase upregulate the angiotensin II receptor.Haemodynamics in microvascular complications in type 1 diabetes.Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance.Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.Store-Operated Ca2+ Channels in Mesangial Cells Inhibit Matrix Protein Expression.Changes of urinary angiotensinogen concentration and its association with urinary proteins in diabetic rats.Angiotensin II induces endoplasmic reticulum stress in podocyte, which would be further augmented by PI3-kinase inhibitionDrug insight: thiazolidinediones and diabetic nephropathy--relevance to renoprotection.Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update.Beneficial effects of thiazolidinediones on diabetic nephropathy in OLETF ratsThe renin-angiotensin system and diabetes: an update.Renin-angiotensin-aldosterone system blockade in diabetes: role of direct renin inhibitors.Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy.Losartan chemistry and its effects via AT1 mechanisms in the kidneyRole of GLP-1 and DPP-4 in diabetic nephropathy and cardiovascular disease.Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cellsCanonical Transient Receptor Potential 6 Channel: A New Target of Reactive Oxygen Species in Renal Physiology and Pathology.Angiotensin II Type 2-Receptor Agonist C21 Reduces Proteinuria and Oxidative Stress in Kidney of High-Salt-Fed Obese Zucker Rats.Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice.Intracerebroventricular infusion of an Angiotensin AT2 receptor agonist Novokinin aggravates some diabetes mellitus-induced alterations in Wistar rats.Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action.Cannabinoid receptor 1 mediates palmitic acid-induced apoptosis via endoplasmic reticulum stress in human renal proximal tubular cells.Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice.Enalapril alters expression of key growth factors in experimental diabetic retinopathy.Angiotensin II activates the GFAT promoter in mesangial cells.High serum enalaprilat in chronic renal failure.Transient glomerular hyperfiltration in the streptozotocin-diabetic Wistar Furth rat.
P2860
Q26782844-D770A3DC-123F-4771-911F-F177C0F7DC17Q28367170-24C07D7A-5D49-498F-B5A7-BD68B2F29E47Q28387627-F3DB8C8C-2F67-44D9-AE0B-E44E0D5B1DF4Q28570142-A9EF3EEA-5363-4A9B-9E35-6F7B2CAC6734Q28579049-36A50809-6E0F-48E0-B15A-71A1CE9BF1D6Q31087420-F36235BC-E68D-4FFD-9CBD-F1F5CA51F7D6Q33242098-C2AE5286-DA17-4491-BF1D-21CA8BCE511DQ33628239-8DB269B6-68B9-4564-B0ED-4D1190510ED2Q33683028-3271A6D0-69B9-42D4-88A6-F43FAB93989EQ33960082-F0E2206B-0FCA-4EAA-A39A-C326A2FF2510Q34333423-980D9402-5A7A-40BD-9412-22FB039EE064Q34579919-70B5BB01-ADDF-4E20-9081-4DB385D2DBA9Q34743589-0EF08293-5555-4DC5-9E14-3EE3B09C738BQ34804249-39889057-1B12-4347-826F-90A18A73DB16Q35174671-B52893E7-02E9-4E4D-B4CF-304DCB17AB7AQ35629267-D7B81A65-F951-4663-91EC-478612CB0B34Q36035236-8763F028-BF5C-4B6F-B350-5F6AF7FEC23BQ36223317-DCE8AB1A-E55C-4DA4-A426-44F9B3C3FD12Q36374983-C750E5EB-8C7F-45B7-863A-1B7198B98611Q36572270-766BD39D-5703-4761-9AFD-F06CF662D5F5Q36577073-53242B5D-6950-4509-9F73-2DB700C56027Q36703450-1D687591-08AE-4598-BD83-4D41DA21DF34Q37065532-7B461CB5-75A3-403E-9EB9-B2E134FC340AQ37344441-6D70D666-64F5-414A-902E-B7A50F9118E6Q37505849-DAD29512-B902-4E85-A47B-EFBC86462E73Q37595295-12B4A4A8-39AF-48AA-A409-E4C61CAD9373Q37595616-1A28ED40-D5C3-4FC3-AA96-E29101960025Q38042110-0A6DF165-AF8F-415F-8232-B4465B545860Q38322138-3296B0FE-C6D2-47B3-97E4-EEB508C61B25Q38758929-3C504480-799E-4A27-9F8B-A10BCD422150Q40238417-7B1B13EC-AB3E-4883-A4B9-BFA8A5AA5029Q40888786-C8090AE7-F818-40DD-B65B-0385BD465CFBQ42696777-3E13B145-E065-4D40-96A8-B4B15B019A03Q42747102-4ED70D85-520C-4849-9FFF-07785F82E783Q43053240-40902ECD-60A3-4850-A558-2BE20EAECAC0Q43148851-C58C1F67-55FA-4CC7-A97B-3C3D16C9E517Q43230857-819DABE3-D9D6-4F8A-B4C8-4A29A785C4B3Q43635187-09AE5CCD-F8B7-4221-A570-11EEBDB8A7FCQ43907296-4D6A22FB-EB82-4958-85DE-D8D9A456D9BCQ44093011-DC24933B-56CB-4E9A-BDB3-D68D3011878D
P2860
The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
The role of angiotensin II in ...... on nonhemodynamic mechanisms.
@en
type
label
The role of angiotensin II in ...... on nonhemodynamic mechanisms.
@en
prefLabel
The role of angiotensin II in ...... on nonhemodynamic mechanisms.
@en
P1476
The role of angiotensin II in ...... on nonhemodynamic mechanisms.
@en
P2093
P304
P356
10.1016/S0272-6386(97)90023-8
P577
1997-01-01T00:00:00Z